Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment
Pharmaceutics · 11.07.2023 · 15 (7) · 1928
DOI: 10.3390/pharmaceutics15071928 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 11.07.2023. Verfasst von Shicui Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Ch…. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Scientists Fund of the National Natural Science Foundation of China, Yunnan Province Natural Science Foundation Project, Bi-Rong Dong Expert Workstation.
Abstract (Originalsprache)
As drug carriers for cancer treatment, stimulus-responsive polymer nanomaterials are a major research focus. These nanocarriers respond to specific stimulus signals (e.g., pH, redox, hypoxia, enzymes, temperature, and light) to precisely control drug release, thereby improving drug uptake rates in cancer cells and reducing drug damage to normal cells. Therefore, we reviewed the research progress in the past 6 years and the mechanisms underpinning single and multiple stimulus-responsive polymer nanocarriers in tumour therapy. The advantages and disadvantages of various stimulus-responsive polymeric nanomaterials are summarised, and the future outlook is provided to provide a scientific and theoretical rationale for further research, development, and utilisation of stimulus-responsive nanocarriers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Key Laboratory of Integrated Traditional Chinese and Western Medicine for Chronic Disease in Prevention and Treatment, Yunnan University of Chinese Medicine, Kunming 650500, China.
- Key Laboratory of Microcosmic Syndrome Differentiation, Yunnan University of Chinese Medicine, Kunming 650500, China.
- Center of Digestive Endoscopy, The First Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, China.
ORCID-Profile: Shicui Luo, Junzi Wu
Förderung
- Young Scientists Fund of the National Natural Science Foundation of China
- Yunnan Province Natural Science Foundation Project
- Bi-Rong Dong Expert Workstation
- Clinical Medical Research Center for Geriatric Diseases
Zitieren
APA
Luo, S., Lv, Z., Yang, Q., Chang, R., & Wu, J. (2023). Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment. Pharmaceutics, 15(7), 1928. https://doi.org/10.3390/pharmaceutics15071928
Vancouver
Luo S, Lv Z, Yang Q, Chang R, Wu J. Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment. Pharmaceutics. 2023;15(7):1928. doi:10.3390/pharmaceutics15071928
BibTeX
@article{Luo2023,
author = {Luo, Shicui and Lv, Zhuo and Yang, Qiuqiong and Chang, Renjie and Wu, Junzi},
title = {Research Progress on Stimulus-Responsive Polymer Nanocarriers for Cancer Treatment},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {7},
pages = {1928},
doi = {10.3390/pharmaceutics15071928}
}
EUVIMED